Stocks rally to start the week, Nasdaq closes at record after Pfizer vaccine approval; Europe stocks close higher after worst week since Feb 
Stocks finished higher Monday following a volatile week on Wall Street, led by reopening stocks as the Food and Drug Administration approved its first Covid-19 vaccine. 
The S&P 500 added 0.8% to reach 4,479.53, just shy of a record close. The tech-heavy Nasdaq Composite rose about 1.5% to 14,942.65 to hit a record closing high. The Dow Jones Industrial Average gained 215.63 points, or 0.6%, to 35,335.71. 
Shares of vaccine makers jumped on Monday after the FDA granted full approval for the two-dose Pfizer-BioNTech vaccine for Covid-19. Pfizer shares rose 2.4%. Its partner BioNTech’s stock jumped 9.5% and Moderna climbed 7.5%. Trillium Therapeutics soared 188% on news that it’ll be acquired by Pfizer. 

The pan-European Stoxx 600 ended the session up 0.7% provisionally, with oil and gas stocks jumping 2.2% to lead the gains. 
On the data front, the euro zone economy lost some momentum in August, but remains on track for strong third-quarter growth, according to preliminary data published Monday. 
IHS Markit’s flash composite PMI for the euro zone, which looks at activity across both manufacturing and services, hit a two-month low of 59.5 in August versus 60.2 in July. 
Switzerland’s Cembra Money Bank plummeted over 30% after terminating a credit card partnership with compatriot retailer Migros. 
Source: CNBC, Investing.com